EMPIRI INC.
Steven Daniel is an accomplished professional with extensive experience in the biotechnology and healthcare sectors, particularly in corporate advisory and business development roles. Currently serving as a Corporate Advisor at EMPIRI INC., Steven has previously held notable positions at companies such as REALM IDx, Inc., Akoya Biosciences, and Sprightly Health, contributing to advancements in integrated diagnostics, gene expression analysis, and health technology platforms. With a strong academic background, including a Ph.D. in Molecular Biology from the University of Wisconsin-Madison and postdoctoral training at Stanford University, Steven has a proven track record in driving innovative solutions in cancer research and diagnostics across multiple organizations.
This person is not in any teams
EMPIRI INC.
A startup biotechnology platform company currently focused on precision oncology. EMPIRI is revolutionizing the way we treat cancer by providing empirical, personalized drug response data before treatments are selected for each patient by oncologists. We are building LDTs for specific cancer indications and a first-in-class automated cancer diagnostic instrument to scale our assays. We are also a 10x Genomic Certified Service Provider for single-cell analysis for clinical and preclinical studies.